Alzheimer’s and Parkinson’s Disease Conference (AD/PDTM 2024) | March 5-9, 2024
March 8, 2024 — Reda et al.
Neuroprotective Mechanisms of Fosgonimeton Against Excitotoxicity in Primary Neuron Culture
March 8, 2024 — Setti et al.
Fosgonimeton Protects Against α-Synuclein-Mediated Pathology in Preclinical Models of Parkinson’s Disease
March 8, 2024 — Moebius et al.
Results From SHAPE: A Phase 2 Trial of Fosgonimeton in Patients with Parkinson’s Disease Dementia or Dementia with Lewy Bodies